Market News & Trends
Bend Research Announces New Facility for High-Potency Drug Candidates
Bend Research Inc. recently announced the addition of a new current Good Manufacturing Practice (cGMP) spray-drying facility. The new facility expands Bend Research's state-of-the-art capabilities…
DPT Laboratories Names New VP & GM of Center of Excellence
DPT Laboratories recently announced that Gene Ciolfi has been promoted to Vice President and General Manager, Site Operations, DPT Lakewood, NJ. Mr. Ciolfi, who joined…
ImmunoGen Announces Significant Phase III Study Results
ImmunoGen, Inc. recently announced that Roche has reported that updated results from its EMILIA Phase III trial show that patients treated with trastuzumab emtansine had a…
Pyramid Laboratories Expands cGMP Services
Pyramid Laboratories, Inc. a premier clinical and commercial parenteral manufacturer, recently announced it has expanded its portfolio of services with the addition of a new…
Synergy Pharmaceuticals Acquires BMS Drug
Synergy Pharmaceuticals Inc. recently announced it has signed an Asset Purchase Agreement with Bristol-Myers Squibb Company and has acquired the assets related to FV-100, an…
Avantor Names New President & CEO
Avantor Performance Materials recently announced the appointment of John M. Steitz as President and Chief Executive Officer. Mr. Steitz assumes these roles from Avantor Chairman…
New Findings Advance Industry Understanding of Standardizing In Vitro Tests for Lipid-Based Formulations
With the push to bring new drugs to market faster, the healthcare industry has made significant advances in utilizing lipid-based drug delivery systems to expedite…
Regulus Therapeutics Files for Multi-Million IPO
Regulus Therapeutics Inc., a biopharmaceutical company founded by Alnylam Pharmaceuticals and Isis Pharmaceuticals, recently announced it has filed a registration statement on Form S-1 with…
TG Therapeutics; Rhizen Pharmaceuticals Ink $250-Million Agreement
TG Therapeutics, Inc. and Rhizen Pharmaceuticals SA recently announced the companies have entered into an exclusive global agreement to collaborate on the development and commercialization…
The Wistar Institute of Philadelphia Signs Agreement With DavosPharma
DavosPharma recently announced it has signed a collaborative agreement with The Wistar Institute of Philadelphia. This agreement provides DMPK, and preclinical IND enabling studies and…
United Drug Acquires Leading Clinical Trials Materials Business
United Drug plc recently announced it has reached an agreement to acquire the UK and US clinical services businesses (combined Bilcare Global Clinical Supplies or…
8/22/2012
United Drug Acquires Leading Clinical Trials Materials Business United Drug plc recently announced it has reached an agreement to acquire the UK and US clinical…
8/15/2012
Quintiles Acquires Company to Advance Personalized Medicine Quintiles recently announced the acquisition of Expression Analysis, Inc. (EA), a premier provider of genomics testing and analysis…
GeNO LLC Receives Two Additional Patents for Inhaled Drug Delivery
GeNO LLC recently announced it has been awarded two new US patents on its proprietary nitric oxide (NO) generation and delivery technology. This brings to…
Oculus Innovative Sciences Announces Licensing Agreement
Oculus Innovative Sciences, Inc. recently announced the exclusive licensing of the company's Microcyn-based human healthcare products in Mexico, South/Central America, and the Caribbean to More…
Protalix BioTherapeutics Receives Clearance to Initiate Study
Protalix BioTherapeutics, Inc. recently announced it has received clearance of its IND application from the US FDA to initiate clinical trials of PRX-102. The company…
Quintiles Acquires Company to Advance Personalized Medicine
Quintiles recently announced the acquisition of Expression Analysis, Inc. (EA), a premier provider of genomics testing and analysis to biopharma, academic, government, and non-profit customers,…
Theorem Clinical Research & Gallus BioPharmaceuticals Announce Exclusive Partnership
Theorem Clinical Research has entered an exclusive partnership with Gallus BioPharmaceuticals in which Gallus will provide process development and clinical and commercial supply for mammalian…
InSite Vision Initiates First Phase III Clinical Study
InSite Vision Incorporated recently announced that patient enrollment has begun in the first Phase III clinical trial of BromSite (ISV-303) for the reduction of pain…
Purac Acquires FiberLive Technology
Purac recently announced it has acquired the FiberLive technology from Vivoxid Ltd., Finland. The acquisition includes the intellectual property of the FiberLive technology and its…
